Cargando…
Cognitive reserve and TMEM106B genotype modulate brain damage in presymptomatic frontotemporal dementia: a GENFI study
Frontotemporal dementia is a heterogeneous neurodegenerative disorder with around a third of cases having autosomal dominant inheritance. There is wide variability in phenotype even within affected families, raising questions about the determinants of the progression of disease and age at onset. It...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445253/ https://www.ncbi.nlm.nih.gov/pubmed/28460069 http://dx.doi.org/10.1093/brain/awx103 |
_version_ | 1783238845193519104 |
---|---|
author | Premi, Enrico Grassi, Mario van Swieten, John Galimberti, Daniela Graff, Caroline Masellis, Mario Tartaglia, Carmela Tagliavini, Fabrizio Rowe, James B. Laforce Jr, Robert Finger, Elizabeth Frisoni, Giovanni B. de Mendonça, Alexandre Sorbi, Sandro Gazzina, Stefano Cosseddu, Maura Archetti, Silvana Gasparotti, Roberto Manes, Marta Alberici, Antonella Cardoso, Manuel J. Bocchetta, Martina Cash, David M. Ourselin, Sebastian Padovani, Alessandro Rohrer, Jonathan D. Borroni, Barbara |
author_facet | Premi, Enrico Grassi, Mario van Swieten, John Galimberti, Daniela Graff, Caroline Masellis, Mario Tartaglia, Carmela Tagliavini, Fabrizio Rowe, James B. Laforce Jr, Robert Finger, Elizabeth Frisoni, Giovanni B. de Mendonça, Alexandre Sorbi, Sandro Gazzina, Stefano Cosseddu, Maura Archetti, Silvana Gasparotti, Roberto Manes, Marta Alberici, Antonella Cardoso, Manuel J. Bocchetta, Martina Cash, David M. Ourselin, Sebastian Padovani, Alessandro Rohrer, Jonathan D. Borroni, Barbara |
author_sort | Premi, Enrico |
collection | PubMed |
description | Frontotemporal dementia is a heterogeneous neurodegenerative disorder with around a third of cases having autosomal dominant inheritance. There is wide variability in phenotype even within affected families, raising questions about the determinants of the progression of disease and age at onset. It has been recently demonstrated that cognitive reserve, as measured by years of formal schooling, can counteract the ongoing pathological process. The TMEM106B genotype has also been found to be a modifier of the age at disease onset in frontotemporal dementia patients with TDP-43 pathology. This study therefore aimed to elucidate the modulating effect of environment (i.e. cognitive reserve as measured by educational attainment) and genetic background (i.e. TMEM106B polymorphism, rs1990622 T/C) on grey matter volume in a large cohort of presymptomatic subjects bearing frontotemporal dementia-related pathogenic mutations. Two hundred and thirty-one participants from the GENFI study were included: 108 presymptomatic MAPT, GRN, and C9orf72 mutation carriers and 123 non-carriers. For each subject, cortical and subcortical grey matter volumes were generated using a parcellation of the volumetric T(1)-weighted magnetic resonance imaging brain scan. TMEM106B genotyping was carried out, and years of education recorded. First, we obtained a composite measure of grey matter volume by graph-Laplacian principal component analysis, and then fitted a linear mixed-effect interaction model, considering the role of (i) genetic status; (ii) educational attainment; and (iii) TMEM106B genotype on grey matter volume. The presence of a mutation was associated with a lower grey matter volume (P = 0.002), even in presymptomatic subjects. Education directly affected grey matter volume in all the samples (P = 0.02) with lower education attainment being associated with lower volumes. TMEM106B genotype did not influence grey matter volume directly on its own but in mutation carriers it modulated the slope of the correlation between education and grey matter volume (P = 0.007). Together, these results indicate that brain atrophy in presymptomatic carriers of common frontotemporal dementia mutations is affected by both genetic and environmental factors such that TMEM106B enhances the benefit of cognitive reserve on brain structure. These findings should be considered in evaluating outcomes in future disease-modifying trials, and support the search for protective mechanisms in people at risk of dementia that might facilitate new therapeutic strategies. |
format | Online Article Text |
id | pubmed-5445253 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-54452532017-05-31 Cognitive reserve and TMEM106B genotype modulate brain damage in presymptomatic frontotemporal dementia: a GENFI study Premi, Enrico Grassi, Mario van Swieten, John Galimberti, Daniela Graff, Caroline Masellis, Mario Tartaglia, Carmela Tagliavini, Fabrizio Rowe, James B. Laforce Jr, Robert Finger, Elizabeth Frisoni, Giovanni B. de Mendonça, Alexandre Sorbi, Sandro Gazzina, Stefano Cosseddu, Maura Archetti, Silvana Gasparotti, Roberto Manes, Marta Alberici, Antonella Cardoso, Manuel J. Bocchetta, Martina Cash, David M. Ourselin, Sebastian Padovani, Alessandro Rohrer, Jonathan D. Borroni, Barbara Brain Original Articles Frontotemporal dementia is a heterogeneous neurodegenerative disorder with around a third of cases having autosomal dominant inheritance. There is wide variability in phenotype even within affected families, raising questions about the determinants of the progression of disease and age at onset. It has been recently demonstrated that cognitive reserve, as measured by years of formal schooling, can counteract the ongoing pathological process. The TMEM106B genotype has also been found to be a modifier of the age at disease onset in frontotemporal dementia patients with TDP-43 pathology. This study therefore aimed to elucidate the modulating effect of environment (i.e. cognitive reserve as measured by educational attainment) and genetic background (i.e. TMEM106B polymorphism, rs1990622 T/C) on grey matter volume in a large cohort of presymptomatic subjects bearing frontotemporal dementia-related pathogenic mutations. Two hundred and thirty-one participants from the GENFI study were included: 108 presymptomatic MAPT, GRN, and C9orf72 mutation carriers and 123 non-carriers. For each subject, cortical and subcortical grey matter volumes were generated using a parcellation of the volumetric T(1)-weighted magnetic resonance imaging brain scan. TMEM106B genotyping was carried out, and years of education recorded. First, we obtained a composite measure of grey matter volume by graph-Laplacian principal component analysis, and then fitted a linear mixed-effect interaction model, considering the role of (i) genetic status; (ii) educational attainment; and (iii) TMEM106B genotype on grey matter volume. The presence of a mutation was associated with a lower grey matter volume (P = 0.002), even in presymptomatic subjects. Education directly affected grey matter volume in all the samples (P = 0.02) with lower education attainment being associated with lower volumes. TMEM106B genotype did not influence grey matter volume directly on its own but in mutation carriers it modulated the slope of the correlation between education and grey matter volume (P = 0.007). Together, these results indicate that brain atrophy in presymptomatic carriers of common frontotemporal dementia mutations is affected by both genetic and environmental factors such that TMEM106B enhances the benefit of cognitive reserve on brain structure. These findings should be considered in evaluating outcomes in future disease-modifying trials, and support the search for protective mechanisms in people at risk of dementia that might facilitate new therapeutic strategies. Oxford University Press 2017-06 2017-04-27 /pmc/articles/PMC5445253/ /pubmed/28460069 http://dx.doi.org/10.1093/brain/awx103 Text en © The Author (2017). Published by Oxford University Press on behalf of the Guarantors of Brain. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Premi, Enrico Grassi, Mario van Swieten, John Galimberti, Daniela Graff, Caroline Masellis, Mario Tartaglia, Carmela Tagliavini, Fabrizio Rowe, James B. Laforce Jr, Robert Finger, Elizabeth Frisoni, Giovanni B. de Mendonça, Alexandre Sorbi, Sandro Gazzina, Stefano Cosseddu, Maura Archetti, Silvana Gasparotti, Roberto Manes, Marta Alberici, Antonella Cardoso, Manuel J. Bocchetta, Martina Cash, David M. Ourselin, Sebastian Padovani, Alessandro Rohrer, Jonathan D. Borroni, Barbara Cognitive reserve and TMEM106B genotype modulate brain damage in presymptomatic frontotemporal dementia: a GENFI study |
title | Cognitive reserve and TMEM106B genotype modulate brain damage in presymptomatic frontotemporal dementia: a GENFI study |
title_full | Cognitive reserve and TMEM106B genotype modulate brain damage in presymptomatic frontotemporal dementia: a GENFI study |
title_fullStr | Cognitive reserve and TMEM106B genotype modulate brain damage in presymptomatic frontotemporal dementia: a GENFI study |
title_full_unstemmed | Cognitive reserve and TMEM106B genotype modulate brain damage in presymptomatic frontotemporal dementia: a GENFI study |
title_short | Cognitive reserve and TMEM106B genotype modulate brain damage in presymptomatic frontotemporal dementia: a GENFI study |
title_sort | cognitive reserve and tmem106b genotype modulate brain damage in presymptomatic frontotemporal dementia: a genfi study |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445253/ https://www.ncbi.nlm.nih.gov/pubmed/28460069 http://dx.doi.org/10.1093/brain/awx103 |
work_keys_str_mv | AT premienrico cognitivereserveandtmem106bgenotypemodulatebraindamageinpresymptomaticfrontotemporaldementiaagenfistudy AT grassimario cognitivereserveandtmem106bgenotypemodulatebraindamageinpresymptomaticfrontotemporaldementiaagenfistudy AT vanswietenjohn cognitivereserveandtmem106bgenotypemodulatebraindamageinpresymptomaticfrontotemporaldementiaagenfistudy AT galimbertidaniela cognitivereserveandtmem106bgenotypemodulatebraindamageinpresymptomaticfrontotemporaldementiaagenfistudy AT graffcaroline cognitivereserveandtmem106bgenotypemodulatebraindamageinpresymptomaticfrontotemporaldementiaagenfistudy AT masellismario cognitivereserveandtmem106bgenotypemodulatebraindamageinpresymptomaticfrontotemporaldementiaagenfistudy AT tartagliacarmela cognitivereserveandtmem106bgenotypemodulatebraindamageinpresymptomaticfrontotemporaldementiaagenfistudy AT tagliavinifabrizio cognitivereserveandtmem106bgenotypemodulatebraindamageinpresymptomaticfrontotemporaldementiaagenfistudy AT rowejamesb cognitivereserveandtmem106bgenotypemodulatebraindamageinpresymptomaticfrontotemporaldementiaagenfistudy AT laforcejrrobert cognitivereserveandtmem106bgenotypemodulatebraindamageinpresymptomaticfrontotemporaldementiaagenfistudy AT fingerelizabeth cognitivereserveandtmem106bgenotypemodulatebraindamageinpresymptomaticfrontotemporaldementiaagenfistudy AT frisonigiovannib cognitivereserveandtmem106bgenotypemodulatebraindamageinpresymptomaticfrontotemporaldementiaagenfistudy AT demendoncaalexandre cognitivereserveandtmem106bgenotypemodulatebraindamageinpresymptomaticfrontotemporaldementiaagenfistudy AT sorbisandro cognitivereserveandtmem106bgenotypemodulatebraindamageinpresymptomaticfrontotemporaldementiaagenfistudy AT gazzinastefano cognitivereserveandtmem106bgenotypemodulatebraindamageinpresymptomaticfrontotemporaldementiaagenfistudy AT cosseddumaura cognitivereserveandtmem106bgenotypemodulatebraindamageinpresymptomaticfrontotemporaldementiaagenfistudy AT archettisilvana cognitivereserveandtmem106bgenotypemodulatebraindamageinpresymptomaticfrontotemporaldementiaagenfistudy AT gasparottiroberto cognitivereserveandtmem106bgenotypemodulatebraindamageinpresymptomaticfrontotemporaldementiaagenfistudy AT manesmarta cognitivereserveandtmem106bgenotypemodulatebraindamageinpresymptomaticfrontotemporaldementiaagenfistudy AT albericiantonella cognitivereserveandtmem106bgenotypemodulatebraindamageinpresymptomaticfrontotemporaldementiaagenfistudy AT cardosomanuelj cognitivereserveandtmem106bgenotypemodulatebraindamageinpresymptomaticfrontotemporaldementiaagenfistudy AT bocchettamartina cognitivereserveandtmem106bgenotypemodulatebraindamageinpresymptomaticfrontotemporaldementiaagenfistudy AT cashdavidm cognitivereserveandtmem106bgenotypemodulatebraindamageinpresymptomaticfrontotemporaldementiaagenfistudy AT ourselinsebastian cognitivereserveandtmem106bgenotypemodulatebraindamageinpresymptomaticfrontotemporaldementiaagenfistudy AT padovanialessandro cognitivereserveandtmem106bgenotypemodulatebraindamageinpresymptomaticfrontotemporaldementiaagenfistudy AT rohrerjonathand cognitivereserveandtmem106bgenotypemodulatebraindamageinpresymptomaticfrontotemporaldementiaagenfistudy AT borronibarbara cognitivereserveandtmem106bgenotypemodulatebraindamageinpresymptomaticfrontotemporaldementiaagenfistudy AT cognitivereserveandtmem106bgenotypemodulatebraindamageinpresymptomaticfrontotemporaldementiaagenfistudy |